MOCS3
Basic information
Region (hg38): 20:50958818-50963929
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MOCS3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 64 | 75 | ||||
missense | 139 | 144 | ||||
nonsense | 7 | |||||
start loss | 3 | |||||
frameshift | 7 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 164 | 67 | 7 |
Variants in MOCS3
This is a list of pathogenic ClinVar variants found in the MOCS3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-50958843-A-C | Uncertain significance (Sep 08, 2023) | |||
20-50958843-A-G | Uncertain significance (Sep 08, 2023) | |||
20-50958844-T-C | Uncertain significance (Aug 16, 2022) | |||
20-50958846-G-T | Uncertain significance (Aug 15, 2022) | |||
20-50958848-T-C | Likely benign (Jun 26, 2022) | |||
20-50958850-C-G | Uncertain significance (Mar 18, 2023) | |||
20-50958850-C-T | Uncertain significance (Jan 28, 2024) | |||
20-50958853-G-A | Uncertain significance (May 18, 2023) | |||
20-50958863-A-C | MOCS3-related disorder | Likely benign (Feb 01, 2024) | ||
20-50958869-C-T | Likely benign (May 30, 2023) | |||
20-50958874-A-G | Uncertain significance (Nov 24, 2023) | |||
20-50958889-A-G | Uncertain significance (Dec 28, 2023) | |||
20-50958890-A-C | Uncertain significance (Mar 24, 2021) | |||
20-50958896-G-A | Uncertain significance (Dec 12, 2023) | |||
20-50958900-G-A | Uncertain significance (Apr 12, 2022) | |||
20-50958911-G-T | Likely benign (Jul 07, 2023) | |||
20-50958918-C-T | Uncertain significance (Nov 08, 2022) | |||
20-50958923-G-A | Likely benign (Jul 12, 2022) | |||
20-50958924-C-T | Likely benign (Aug 31, 2022) | |||
20-50958927-G-A | not specified | Uncertain significance (Dec 30, 2023) | ||
20-50958927-G-T | Uncertain significance (Aug 02, 2021) | |||
20-50958928-C-G | Uncertain significance (Nov 22, 2022) | |||
20-50958932-G-C | Uncertain significance (Nov 02, 2023) | |||
20-50958936-C-G | Uncertain significance (Jan 01, 2024) | |||
20-50958951-G-C | Uncertain significance (May 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MOCS3 | protein_coding | protein_coding | ENST00000244051 | 1 | 2458 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000184 | 0.453 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.671 | 246 | 277 | 0.887 | 0.0000154 | 2880 |
Missense in Polyphen | 63 | 81.343 | 0.77449 | 880 | ||
Synonymous | 0.00706 | 129 | 129 | 0.999 | 0.00000681 | 1072 |
Loss of Function | 0.644 | 10 | 12.5 | 0.803 | 6.76e-7 | 136 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a central role in 2-thiolation of mcm(5)S(2)U at tRNA wobble positions of cytosolic tRNA(Lys), tRNA(Glu) and tRNA(Gln). Also essential during biosynthesis of the molybdenum cofactor. Acts by mediating the C-terminal thiocarboxylation of sulfur carriers URM1 and MOCS2A. Its N-terminus first activates URM1 and MOCS2A as acyl-adenylates (-COAMP), then the persulfide sulfur on the catalytic cysteine is transferred to URM1 and MOCS2A to form thiocarboxylation (-COSH) of their C-terminus. The reaction probably involves hydrogen sulfide that is generated from the persulfide intermediate and that acts as nucleophile towards URM1 and MOCS2A. Subsequently, a transient disulfide bond is formed. Does not use thiosulfate as sulfur donor; NFS1 probably acting as a sulfur donor for thiocarboxylation reactions. {ECO:0000255|HAMAP-Rule:MF_03049, ECO:0000269|PubMed:15073332, ECO:0000269|PubMed:19017811}.;
- Pathway
- Sulfur relay system - Homo sapiens (human);Metabolism;Molybdenum cofactor biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;molybdenum cofactor biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.196
Intolerance Scores
- loftool
- 0.641
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.188
- hipred
- N
- hipred_score
- 0.309
- ghis
- 0.563
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.918
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mocs3
- Phenotype
Gene ontology
- Biological process
- tRNA wobble uridine modification;tRNA wobble position uridine thiolation;Mo-molybdopterin cofactor biosynthetic process;enzyme active site formation via cysteine modification to L-cysteine persulfide;molybdopterin cofactor biosynthetic process;protein urmylation;tRNA thio-modification
- Cellular component
- cytoplasm;cytosol
- Molecular function
- thiosulfate sulfurtransferase activity;protein binding;ATP binding;nucleotidyltransferase activity;sulfurtransferase activity;URM1 activating enzyme activity;metal ion binding;molybdopterin-synthase sulfurtransferase activity;molybdopterin-synthase adenylyltransferase activity